SmartWATCHes for Detection of Atrial Fibrillation
WATCHAF
1 other identifier
observational
651
2 countries
2
Brief Summary
In this trial the Preventives Heartbeats algorithm will be tested in two wearable devices for its specificity and sensitivity to distinguish between AF and SR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2016
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2016
CompletedFirst Posted
Study publicly available on registry
November 7, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJanuary 16, 2018
January 1, 2018
1 year
November 2, 2016
January 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correct detection of AF
Sensitivity and specificity of the Preventicus Heartbeats App to distinguish between AF and SR
5 minutes
Secondary Outcomes (2)
Differences in correct detection of AF between Smartwatch and Wristband
5 minutes
Reduced sensitivity and specificity in patients with >2% premature beats
5 minutes
Study Arms (2)
AF
Five minutes pulse wave recording in patients with atrial fibrillation at the time of recruitment
SR
Five minutes pulse wave recording in patients with sinus rhythm at the time of recruitment
Interventions
Patients will wear a smart watch and a wristband each at one arm. A standard egg (lead I) and pig signals from the wearables will be recorded for five minutes.
Eligibility Criteria
Patients at the University Hospital Basel
You may qualify if:
- Subjects of legal age,
- patients with either sinus rhythm (Group SR) or atrial fibrillation (Group AF)
- signed informed consent form
You may not qualify if:
- Legally incompetent persons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universitätsmedizin Greifswald, Klinik und Poliklinik für Innere Medizin B
Greifswald, 17475, Germany
University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
Related Publications (2)
Krivoshei L, Weber S, Burkard T, Maseli A, Brasier N, Kuhne M, Conen D, Huebner T, Seeck A, Eckstein J. Smart detection of atrial fibrillationdagger. Europace. 2017 May 1;19(5):753-757. doi: 10.1093/europace/euw125.
PMID: 27371660RESULTDorr M, Nohturfft V, Brasier N, Bosshard E, Djurdjevic A, Gross S, Raichle CJ, Rhinisperger M, Stockli R, Eckstein J. The WATCH AF Trial: SmartWATCHes for Detection of Atrial Fibrillation. JACC Clin Electrophysiol. 2019 Feb;5(2):199-208. doi: 10.1016/j.jacep.2018.10.006. Epub 2018 Nov 28.
PMID: 30784691DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Eckstein, MD, PhD
University Hospital, Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2016
First Posted
November 7, 2016
Study Start
December 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
January 16, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share